Iron availability and infection

Weinberg, 2008, Iron out-of-balance: a risk factor for acute and chronic diseases, Hemoglobin, 31, 117, 10.1080/03630260701680805

Schade, 1944, Raw hen egg white and the role of iron in growth inhibition of Shigella dysenteriae, Staphylococcus aureus, Escherichia coli and Saccharomyces cerevisiae, Science, 100, 14, 10.1126/science.100.2584.14

Weinbetrg, 1984, Iron withholding: a defense against infection and neoplasia, Physiol. Revs., 64, 65, 10.1152/physrev.1984.64.1.65

Weinberg, 2005, Iron withholding as a defense strategy, 255

Dhaenens, 1997, Identification, characteristics and immunogenicity of the lactoferrin binding protein from Helicobacter pylori, Infec. Immun., 65, 514, 10.1128/IAI.65.2.514-518.1997

Gray-Owen, 1993, The interaction of primate transferrins with receptors on bacteria pathogenic to humans, Microb. Pathogen., 14, 389, 10.1006/mpat.1993.1038

Holbein, 1981, Enhancementg of Neisseria meningitidis infection in mice by addition of iron bound to transferrin, Infec. Immun., 34, 120, 10.1128/IAI.34.1.120-125.1981

Zarantonelli, 2007, Transgenic mice expressing human transferrin as a model for the study of meningococcal infection, Infec. Immun., 75, 5609, 10.1128/IAI.00781-07

Gray-Owen, 1996, Bacterial transferrin and lactoferrin receptors, Trends Microbiol., 4, 185, 10.1016/0966-842X(96)10025-1

Coulanges, 1997, Utilization of iron catecholamine complexes involving ferric reductase activity in Listeria monocytogenes, Infec. Immun., 65, 2778, 10.1128/IAI.65.7.2778-2785.1997

Raymond, 2004, Bioochemical and biophysical properties of siderophores, 3

Vartivarian, 1995, Iron acquisition by Cryptococcus neoformans, J. Med. Vet. Mycol., 33, 151, 10.1080/02681219580000331

Knight, 2002, Reductive iron uptake by Candid albicans; role of copper, iron and the TUP1 regulator, Microbiology SGM, 148, 29, 10.1099/00221287-148-1-29

Perkins-Balding, 2004, Iron transport systems in Neisseria meningitidis, Microbiol. Mol. Biol. Res., 68, 154, 10.1128/MMBR.68.1.154-171.2004

Payne, 2004, Pathogenic Escherichia coli, Shigella, and Salmonella, 199

Watanabe, 1997, Hemoglobin is utilized by Candida albicans in the hyphal form but not in the yeast form, Biochem. Biophys. Res. Commun., 232, 350, 10.1006/bbrc.1997.6247

Anderson, 2001, Selection for expression of the gonococcal hemoglobin receptor, J. Infec. Dis., 184, 1621, 10.1086/324564

Larson, 2004, Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source, Mol. Microbiol., 53, 807, 10.1111/j.1365-2958.2004.04169.x

Whitby, 2006, Burkholderia cenanepacia utilizes ferritin as an iron source, Med. Microbiol., 55, 661, 10.1099/jmm.0.46199-0

Mashburn, 2005, Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo culture, J. Bacteriol., 187, 556, 10.1128/JB.187.2.554-566.2005

Barnewell, 1999, Ehrlichia chaffensis and E. sennetsu but not the human granulocytic agent, colocalize with transferrin receptor and upregulate transferrin receptor mRNA by activating iron responsive protein 1, Infec. Immun., 67, 2258, 10.1128/IAI.67.5.2258-2265.1999

Howe, 1999, Coxiella burnetii infection increases transferrin receptor on J774A.1 cells, Infec. Immun., 67, 3236, 10.1128/IAI.67.7.3236-3241.1999

Weinberg, 2000, Microbial pathogens with impaired ability to acquire host iron, BioMetals, 13, 85, 10.1023/A:1009293500209

Wright, 1981, Roles of iron in the pathogenesis of Vibrio vulnificus, Infec. Immun., 34, 503, 10.1128/IAI.34.2.503-507.1981

Walton, 1976, Factors affecting the susceptibility of staphylococci to killing by the cationic proteins from rabbit polymorphonuclear leucocytes: the effects of alteration of cellular energetics and of various iron compounds, Br. J. Exp. Pathol., 57, 560

Lee, 1979, Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. V. The significance of the coordinated iron component, Surgery, 86, 41

Weinberg, 2004, Suppression of bacterial biofilm formation by iron limitation, Med. Hypoth., 63, 863, 10.1016/j.mehy.2004.04.010

Weinberg, 1990, Roles of trace metals in transcriptional control of secondary metabolism, BioMetals, 2, 191

Ojha, 2007, The role of iron in Mycobacterium smegmatis biofilm formation; the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth, Mol. Microbiol., 66, 468, 10.1111/j.1365-2958.2007.05935.x

Weinberg, 1996, Iron withholding: a defense against viral infections, BioMetals, 9, 393, 10.1007/BF00140609

Weinberg, 2002, Iron and HIV infection, 132

Traore, 2004, The effect of iron overload on in vitro HIV infection, J. Clin. Virol., 31, S92, 10.1016/j.jcv.2004.09.011

Drakesmith, 2005, HIV-1 Nef down-reegulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis, Proc. Natl. Acad. Sci., US, 102, 11017, 10.1073/pnas.0504823102

Gordeuk, 2006, The association of serum ferritin and transferrin receptor concentrations with mortality in women with known immunodeficiency virus infection, Haematologica, 91, 739

McDermid, 2007, Elevated iron status strongly predicts mortality in West African adults with HIV infection, J. Acquir. Immune Defic. Synd., 46, 498, 10.1097/QAI.0b013e31815b2d4b

Weinberg, 2007, Antibiotic properties and applications of lactoferrin, Curr. Pharm. Design, 13, 801, 10.2174/138161207780363095

Pietrangelo, 2006, Molecular insights into the pathogenesis of hereditary hemochromatosis, Gut, 55, 564, 10.1136/gut.2005.078063

Byrd, 1994, Cytokines and legionellosis, Biotherapy, 7, 179, 10.1007/BF01878484

M. Nairz, G. Fritsche, P. Brunner, K. Hantke, G. Weiss, Interferon-ý limits the availability of iron for intramacrophage Salmonella typhimurium, Eur. J. Immunol. (2008)in press.

Flo, 2004, Lipocalin 2 mediates an innate immune response to bacterial infection by sequestering iron, Nature, 432, 917, 10.1038/nature03104

Fluckinger, 2004, Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores, Antimicrob. Agents Chemother., 48, 3367, 10.1128/AAC.48.9.3367-3372.2004

Abergel, 2007, Anthrax pathogen evades the mammalian immune system through stealth siderophore production, Proc. Natl. Acad. Sci., U.S.A., 103, 18479

Palmer, 1997, Does occupational exposure to iron promote infection?, Occupat. Environ. Med., 54, 529, 10.1136/oem.54.8.529

Cordes, 1981, A cluster of Acenitobacter pneumonia in foundry workers, Ann. Intern. Med., 95, 688, 10.7326/0003-4819-95-6-688

Weinberg, 1999, The development of awareness of the carcinogenic hazard of inhaled iron, Oncol. Res., 11, 109

Nuorte, 2000, Cigarette smoking and invasive pneumococcal disease, N. Engl. J. Med., 342, 681, 10.1056/NEJM200003093421002

Fischer, 1997, Tobacco smoke as a risk factor for meningococcal disease, Ped. Infec. Dis., 16, 979, 10.1097/00006454-199710000-00015

Hajjeb, 1999, Cryptococcus population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected patients, J. Infec. Dis., 179, 449, 10.1086/314606

Murray, 1975, Refeeding malaria and hyperferremia, The Lancet, i, 653, 10.1016/S0140-6736(75)91758-4

MacFarlane, 1972, Transferrin and Staphylococcus aureus in kwashiorkor, Am. J. Clin. Pathol., 57, 587, 10.1093/ajcp/57.5.587

Gangaidzo, 2001, Association of pulmonary tuberculosis with increased dietary iron, J. Infec. Dis., 184, 936, 10.1086/323203

Melby, 1982, Septicemia due to Yersinia enterocolitica after oral overdoses of iron, Br. Med. J., 285, 467, 10.1136/bmj.285.6340.467

Haddock, 1991, Infant diet and salmonellosis, Am. J. Publ. Health, 81, 997, 10.2105/AJPH.81.8.997

Weinberg, 2001, Iron, infection and sudden infant death, Med. Hypoth., 56, 731, 10.1054/mehy.2001.1328

Raha-Chowdbury, 1996, Blood ferritin concentrations in newborn infants and the sudden infant death syndrome, J. Clin. Pathol., 49, 168, 10.1136/jcp.49.2.168

Barry, 1988, Iron and infection, Br. Med. J., 296, 1736, 10.1136/bmj.296.6638.1736-a

Oppenheimer, 1986, Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua, New Guinea. Trans. Roy. Soc. Trop. Med. Hyg., 80, 603, 10.1016/0035-9203(86)90154-9

Feldman, 2002, Iron administration and clinical outcome in hemodialysis patients, J. Am. Soc. Nephrol., 13, 542, 10.1681/ASN.V133734

Black, 1960, Salmonellosis — review of some unusual aspects, N. Engl. J. Med., 262, 811, 10.1056/NEJM196004212621606

McGregor, 1972, Immunology of malaria infection and its possible consequences, Br. Med. Bull., 28, 22, 10.1093/oxfordjournals.bmb.a070886

Norcross, 1963, Hematological manifestations of malignant disease, Med. Clin. No. Amer., 47, 345, 10.1016/S0025-7125(16)33592-1

Durken, 2000, Impaired antioxidant defense and increased nontransferrin-bound iron during high dose chemotherapy and radiochemotherapy preceeding bone marrow transplantation, Free Radic. Biol. Med., 28, 887, 10.1016/S0891-5849(00)00174-X

Artis, 1982, A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability, Diabetes, 31, 1109, 10.2337/diabetes.31.12.1109

Khan, 2007, Association of hemochromatosis with infectious diseases: expanding spectrum, Internat. J. Infec. Dis., 11, 482, 10.1016/j.ijid.2007.04.007

Yu, 2007, Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections, Emerging Infec. Dis., 13, 986, 10.3201/eid1307.070187

Weinberg, 2008, Survival advantage of the hemochromatosis C282Y mutation, Persp. Biol. Med., 51, 98, 10.1353/pbm.2008.0001

Myers, 2002, A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events, Transfusion, 42, 1135, 10.1046/j.1537-2995.2002.00186.x

Fleming, 2002, Dietary factors associated with the risk of high iron sores in the elderly Framingham heart study cohort, Am. J. Clin. Nutr., 76, 1375, 10.1093/ajcn/76.6.1375

Mandel, 2004, Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases, Free Rad. Biol. Med., 37, 304, 10.1016/j.freeradbiomed.2004.04.012

Weinberg, 2007, Iron loading in humans: a risk factor for enhanced morbidity and mortality, J. Nutr. Environ. Med., 16, 43, 10.1080/13590840601167685

Drakesmith, 2008, Viral infection and iron metabolism, Nature Rev. Microbiol., 6, 541, 10.1038/nrmicro1930

L.R. Zacharski, B.K. Chow, P.S. Howes, G. Shamayena, J.A. Baron, R.L. Dalman, D.J. Malenka, C.K. Ozaki, P.W. Lavori, Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J. Nat'l. Canc. Inst. 100 (in press).

Mabeza, 1999, Iron chelation therapy for malaria: a review, Pharmacol. Ther., 81, 53, 10.1016/S0163-7258(98)00037-0

Daly, 1989, Mucormycosis: association with deferoxamine therapy, Am. J. Med., 87, 468, 10.1016/S0002-9343(89)80836-8

Weinberg, 2006, Therapeutic potential of iron chelation in diseases associated with iron mismanagemt, J. Pharm. Pharmacol., 58, 575, 10.1211/jpp.58.5.0001

Byrd, 1991, Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron, J. Clin. Invest., 88, 351, 10.1172/JCI115301

Newman, 1994, Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of iron and is therapeutric in a murine model of histoplasmosis, J. Clin. Invest., 93, 1422, 10.1172/JCI117119

Olakanmi, 2000, Gallium disrupts iron metabolism of mycobacteria residing within human macrophages, Infec. Immun., 68, 5619, 10.1128/IAI.68.10.5619-5627.2000

Kaneko, 2007, The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity, J. Clin. Invest., 106

Bland, 2004, The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation, Antimicrob. Agents Chemother., 48, 1983, 10.1128/AAC.48.6.1983-1988.2004